Scientific Sessions 2025  /  New Technologies for Managing Ventricular Arrhythmias and Sudden Cardiac Death  /  Will Wearable Technologies Diagnose and Prevent VT and Sudden Cardiac Death?
Logo

American Heart Association

  48
  0

Final ID:

Will Wearable Technologies Diagnose and Prevent VT and Sudden Cardiac Death?

  • Poole, Jeanne  ( UW , Seattle , Washington , United States )
  • Tzou, Wendy  ( UNIVERSITY OF COLORADO , Aurora , Colorado , United States )
  • Russo, Andrea  ( Cooper University Health Care , Moorestown , New Jersey , United States )
  • Zeitler, Emily  ( Dartmouth-Hitchcock Medical Center , Lebanon , New Hampshire , United States )
    • Author Disclosures:
    Jeanne Poole: DO have relevant financial relationships ; Researcher:Biotronik:Active (exists now) ; Researcher:Kestra Medical:Active (exists now) ; Researcher:AtriCure:Active (exists now) ; Researcher:Boston Scientific:Active (exists now) | Wendy Tzou: DO have relevant financial relationships ; Independent Contractor:American Heart Association:Active (exists now) ; Consultant:Kardium:Active (exists now) ; Advisor:Medtronic:Active (exists now) ; Speaker:Medtronic:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Advisor:Boston Scientific:Active (exists now) ; Speaker:Boston Scientific:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) ; Speaker:Abbott:Active (exists now) ; Advisor:Abbott:Active (exists now) ; Consultant:Abbott:Active (exists now) ; Researcher:Biosense Webster/J&J MedTech:Active (exists now) ; Advisor:Biosense Webster/J&J MedTech:Active (exists now) ; Speaker:Biosense Webster/J&J MedTech:Active (exists now) ; Consultant:Biosense Webster/J&J MedTech:Active (exists now) | Andrea Russo: DO have relevant financial relationships ; Research Funding (PI or named investigator):Abbott, Bayer, Boston Scientific, Medtronic and Novartis:Active (exists now) ; Royalties/Patent Beneficiary:Royalties (writing/editing): UpToDate:Active (exists now) ; Other (please indicate in the box next to the company name):Fellowship support: Medtronic:Active (exists now) ; Consultant:Abbott, Atricure, Bayer, Sanofi:Past (completed) ; Consultant:Biosense Webster, Biotronik, Boston Scientific, Medtronic, Orchestra BioMed, PaceMate :Active (exists now) | Emily Zeitler: DO have relevant financial relationships ; Advisor:medtronic:Active (exists now) ; Consultant:philips:Active (exists now) ; Researcher:biosense webster/ J&J:Active (exists now) ; Researcher:boston scientific:Active (exists now) ; Researcher:sanofi:Active (exists now) ; Consultant:boston scientific:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

New Technologies for Managing Ventricular Arrhythmias and Sudden Cardiac Death

Saturday, 11/08/2025 , 03:15PM - 04:30PM

Cardiovascular Seminar

More abstracts on this topic:
Predicting the future: new risk stratifications for sudden cardiac death

Dominic Paari, Tseng Zian, Albert Christine

When and which patient to use PFA for VT ablation

Turagam Mohit, Koruth Jacob, Tung Roderick

More abstracts from these authors:
Panelist

Russo Andrea

Discussant: DECAF

Russo Andrea

You have to be authorized to contact abstract author. Please, Login
Not Available